BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26277786)

  • 21. The Thr300Ala variant of ATG16L1 is associated with decreased risk of brain metastasis in patients with non-small cell lung cancer.
    Li QX; Zhou X; Huang TT; Tang Y; Liu B; Peng P; Sun L; Wang YH; Yuan XL
    Autophagy; 2017 Jun; 13(6):1053-1063. PubMed ID: 28441070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases.
    Namba Y; Kijima T; Yokota S; Niinaka M; Kawamura S; Iwasaki T; Takeda Y; Kimura H; Okada T; Yamaguchi T; Nakagawa M; Okumura Y; Maeda H; Ito M
    Clin Lung Cancer; 2004 Sep; 6(2):123-8. PubMed ID: 15476598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miRNA-197 and miRNA-184 are associated with brain metastasis in EGFR-mutant lung cancers.
    Remon J; Alvarez-Berdugo D; Majem M; Moran T; Reguart N; Lianes P
    Clin Transl Oncol; 2016 Feb; 18(2):153-9. PubMed ID: 26199015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNAi screen identifies essential regulators of human brain metastasis-initiating cells.
    Singh M; Venugopal C; Tokar T; Brown KR; McFarlane N; Bakhshinyan D; Vijayakumar T; Manoranjan B; Mahendram S; Vora P; Qazi M; Dhillon M; Tong A; Durrer K; Murty N; Hallet R; Hassell JA; Kaplan DR; Cutz JC; Jurisica I; Moffat J; Singh SK
    Acta Neuropathol; 2017 Dec; 134(6):923-940. PubMed ID: 28766011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Checkpoint inhibitors in the treatment of brain metastases of non-small-cell lung cancer and melanoma.
    Kourie HR; Kanaan H; Awada G; Awada AH
    Future Oncol; 2017 May; 13(12):1097-1103. PubMed ID: 28326837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer.
    Tomasini P; Serdjebi C; Khobta N; Metellus P; Ouafik L; Nanni I; Greillier L; Loundou A; Fina F; Mascaux C; Barlesi F
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of adenylate cyclase-associated protein 1 may predict brain metastasis in non-small cell lung cancer.
    Xie SS; Tan M; Lin HY; Xu L; Shen CX; Yuan Q; Song XL; Wang CH
    Oncol Rep; 2015 Jan; 33(1):363-71. PubMed ID: 25371324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of choline levels and tumor perfusion in brain metastases assessed with proton MR spectroscopy and dynamic susceptibility contrast-enhanced perfusion weighted MRI.
    Huang BY; Kwock L; Castillo M; Smith JK
    Technol Cancer Res Treat; 2010 Aug; 9(4):327-37. PubMed ID: 20626199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of accurate reference genes for RT-qPCR analysis of formalin-fixed paraffin-embedded tissue from primary non-small cell lung cancers and brain and lymph node metastases.
    Søes S; Sørensen BS; Alsner J; Overgaard J; Hager H; Hansen LL; Kristensen LS
    Lung Cancer; 2013 Aug; 81(2):180-6. PubMed ID: 23643276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiographic patterns and survival of patients with early and late brain metastases in EGFR wild type and mutant non small cell lung cancer.
    Yuan R; Yamada A; Weber B; Ho C
    J Neurooncol; 2016 May; 127(3):525-33. PubMed ID: 26780337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases.
    Hendriks LE; Troost EG; Steward A; Bootsma GP; De Jaeger K; van den Borne BE; Dingemans AM
    Acta Oncol; 2014 Jul; 53(7):945-51. PubMed ID: 24754845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain metastases: pathobiology and emerging targeted therapies.
    Preusser M; Capper D; Ilhan-Mutlu A; Berghoff AS; Birner P; Bartsch R; Marosi C; Zielinski C; Mehta MP; Winkler F; Wick W; von Deimling A
    Acta Neuropathol; 2012 Feb; 123(2):205-22. PubMed ID: 22212630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amplification and overexpression of CMET is a common event in brain metastases of non-small cell lung cancer.
    Preusser M; Streubel B; Berghoff AS; Hainfellner JA; von Deimling A; Widhalm G; Dieckmann K; Wöhrer A; Hackl M; Zielinski C; Birner P
    Histopathology; 2014 Nov; 65(5):684-92. PubMed ID: 25039982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-associated calcium signal transducer 2 regulates neovascularization of non-small-cell lung cancer via activating ERK1/2 signaling pathway.
    Guo X; Zhu X; Zhao L; Li X; Cheng D; Feng K
    Tumour Biol; 2017 Mar; 39(3):1010428317694324. PubMed ID: 28345466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The incidence and clinical impact of bone metastases in non-small cell lung cancer.
    Kuchuk M; Kuchuk I; Sabri E; Hutton B; Clemons M; Wheatley-Price P
    Lung Cancer; 2015 Aug; 89(2):197-202. PubMed ID: 26003503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension and risk of brain metastasis from small cell lung cancer: a retrospective follow-up study.
    Sahmoun AE; Case LD; Chavour S; Kareem S; Schwartz GG
    Anticancer Res; 2004; 24(5B):3115-20. PubMed ID: 15510598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. αv-Integrin isoform expression in primary human tumors and brain metastases.
    Vogetseder A; Thies S; Ingold B; Roth P; Weller M; Schraml P; Goodman SL; Moch H
    Int J Cancer; 2013 Nov; 133(10):2362-71. PubMed ID: 23661241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival but not brain metastasis response relates to lung cancer mutation status after radiosurgery.
    Shin SM; Cooper BT; Chachoua A; Butler J; Donahue B; Silverman JS; Kondziolka D
    J Neurooncol; 2016 Feb; 126(3):483-91. PubMed ID: 26520640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for brain metastases in locally advanced non-small cell lung cancer with definitive chest radiation.
    Ji Z; Bi N; Wang J; Hui Z; Xiao Z; Feng Q; Zhou Z; Chen D; Lv J; Liang J; Fan C; Liu L; Wang L
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):330-7. PubMed ID: 24725335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy.
    Zeng YD; Liao H; Qin T; Zhang L; Wei WD; Liang JZ; Xu F; Dinglin XX; Ma SX; Chen LK
    Oncotarget; 2015 Apr; 6(10):8366-76. PubMed ID: 25788260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.